Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOEX.L Regulatory News (OEX)

  • There is currently no data for OEX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Securities and Cleansing Notice

22 Mar 2022 07:00

RNS Number : 5742F
Oilex Ltd
22 March 2022
 

ASX - RNS Announcement

22 March 2022

 

ASX: OEX

AIM: OEX

 

 

ISSUE OF SECURITIES AND CLEANSING NOTICE

 

(Oilex or the Company) wishes to advise that following shareholder approval received at the 17 February 2022 Shareholder Meeting, it has issued the following securities:

 

· 711,295,152 unquoted options (Placement Options). The Placement Options are exercisable at GBP 0.28 pence (0.518 AUD cents) per share on or before 31 December 2022. The Options were issued to shareholders as a one free attaching unquoted option for every two Placement Shares subscribed for, in the January 2022 placement,

 

· 54,839,185 unquoted options, exercisable at GBP 0.14 pence (0.259 AUD cents) on or before 31 December 2023 (Fee Options), to Novum Securities.

 

Exercise of Options

Novum has now exercised the 54,839,185 unquoted Fee Options into fully paid ordinary shares.

 

AIM Admission and Total Voting Rights

 

Application has been made to the London Stock Exchange plc for the admission of 54,839,185 Shares to trade on AIM (Admission). Admission of the Shares is expected to become effective and dealings to commence at 8.00 a.m. on 24 March 2022. Following Admission, the Company will have 7,167,790,704 shares in issue. The Company does not currently hold any shares in treasury. Accordingly, the total number of voting rights will be 7,167,790,704.

 

Section 708A(5)(e) Statement

 

The Corporations Act (Cth) (Act) restricts the on-sale of securities issued without disclosure, unless the sale is exempt under section 708 or 708A of the Act. By giving this notice, the on sale of the Shares noted above will fall within the exemption in section 708A(5) of the Act.

 

Pursuant to the issue of the 54,839,185 Ordinary Shares on 17 March 2022, Oilex gives notice under section 708A(5)(e) of the Act that:

 

1) Oilex issued the Shares without disclosure to investors under Part 6D.2 of the Act;

 

2) As at the date of this notice, Oilex has complied with:

a) the provisions of Chapter 2M of the Act as they apply to Oilex; and

b) section 674 of the Act; and

 

3) As at the date of this notice, there is no information:

(i) That has been excluded from a continuous disclosure notice in accordance with the ASX Listing Rules; and

(ii) That investors and their professional advisers would reasonably require for the purpose of making an informed assessment of:

A. The assets and liabilities, financial position and performance, profits and losses and prospects of the Company; or

B. The rights and liabilities attaching to the Shares.

 

The relevant Appendix 2A is lodged via ASX on-line forms.

 

For and on behalf of Oilex Ltd

Suzie Foreman

Company Secretary

 

 

 

For further information, please contact:

 

Investor Enquires

Oilex Ltd

Roland Wessel

Chief Executive Officer

Email: oilex@oilex.com.au

Tel: +61 8 9485 3200

Australia

AIM Broker

Novum Securities

Broker

Colin Rowbury

Email: crowbury@novumsecurities.com

Tel: +44 20 7399 9427

UK

AIM Nominated Adviser

Strand Hanson Limited

Nominated Adviser

Rory Murphy/Ritchie Balmer

Email: oilex@strandhanson.co.uk

Tel: +44 20 7409 3494

UK

Media Enquires (UK)

Vigo Communications

Public Relations

Patrick d'Ancona/Chris McMahon

Email: patrick.dancona@vigocomms.com

chris.mcmahon@vigocomms.com

Tel:+ 44 20 7390 0230

UK

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEJTMFTMTJTMFT
Date   Source Headline
3rd Jan 20207:00 amRNSIssue of Securities
31st Dec 20198:31 amRNSExercise of Options and Underwriting
23rd Dec 20197:30 amRNSEast Irish Sea Licence Acquisition
23rd Dec 20197:15 amRNSBids for Cambay Now Closed
16th Dec 20197:00 amRNSExtension for Acqn of Cooper-Eromanga Licences
2nd Dec 20197:00 amRNSExtension of Bid closing Date for Cambay
29th Nov 20197:57 amRNSIssue of Options Securities
27th Nov 20191:15 pmRNSUpdated Constitution
27th Nov 20197:00 amRNSResults of the Annual General Meeting
26th Nov 20198:53 amRNSCambay PSC Update
11th Nov 20192:05 pmRNSSecond Price Monitoring Extn
11th Nov 20192:00 pmRNSPrice Monitoring Extension
11th Nov 20197:00 amRNSExtension of Bid Closing Date for Cambay
7th Nov 20197:37 amRNSChange of Interests of Substantial Holder
5th Nov 20197:00 amRNSIssue of Securities
31st Oct 201912:54 pmRNSSeptember 2019 Quarterly Report
30th Oct 20197:57 amRNSExpanded Equity Capital Raising
28th Oct 20197:00 amRNS2019 AGM Notice of Meeting
28th Oct 20197:00 amRNS2019 Annual Report to Shareholders
22nd Oct 20199:01 amRNSChange of Interests of Substantial Shareholder
21st Oct 201910:15 amRNSIssue of Securities
18th Oct 201912:32 pmRNSCambay PSC Update
15th Oct 20197:00 amRNSIssue of Securities
10th Oct 20194:12 pmRNSNotice of Change of Interest of Substantial Holder
1st Oct 20198:26 amRNSAnnual Report 2019- Financial Report
1st Oct 20198:26 amRNSAnnual Report - Directors Report
1st Oct 20198:21 amRNSAnnual Report - Business Review
1st Oct 20198:20 amRNSAnnual Report - Chairmans Review
1st Oct 20197:00 amRNSAppendix 4G
1st Oct 20197:00 amRNSAmendment to Loan Funding Agreement
1st Oct 20197:00 amRNSExtension of Exclusivity Agreement
1st Oct 20197:00 amRNSCorporate Governance Statement
30th Sep 20198:45 amRNSEquity Raise of GBP0.6m
30th Sep 20197:00 amRNSExecutive Contract Extensions
27th Sep 20192:16 pmRNSCommencement of Cambay Sale Process
27th Sep 20197:00 amRNSAcquisition of Major Cooper-Eromanga Acreage
27th Sep 20197:00 amRNSIssue of Series A Loan Options
24th Sep 20192:01 pmRNSTermination of Arbitration Proceedings
19th Sep 20197:00 amRNSResults of General Meeting
18th Sep 20197:48 amRNSUpdate on Cooper Basin and Cambay
16th Sep 20197:00 amRNSExclusivity Agreement - East Irish Sea Licences
12th Sep 20197:00 amRNSGood Oil Investor Presentation - September 2019
9th Sep 20199:08 amRNSDispute Resolution with GSPC
6th Sep 20197:00 amRNSChairman to Drive Cooper Basin Strategy
5th Sep 20197:00 amRNSAppendix 3X P Schwarz
4th Sep 20198:22 amRNSAppointment of UK Based Non-Executive Director
20th Aug 20197:00 amRNSNotice of General Meeting - 19 September 2019
16th Aug 201911:54 amRNSJPDA Arbitration - Counterclaim for US$23.3m
15th Aug 20197:00 amRNSNotice of Change of Interest of Substantial Holder
14th Aug 20198:44 amRNSIssue of Consideration Securities

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.